Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of MEMANXA 10 vs Ebixa Under Fasting Conditions
TCTR20250204002Phase 1Completed
- Sponsor
- Government Pharmaceutical Organization
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of memantine (2 arms), sponsored by Government Pharmaceutical Organization. Started Mar 2025; status: completed.
02
Drugs
memantine
Beyond the preview
Go deeper on TCTR20250204002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250204002.